New drug targets 'Undruggable' cancer mutation in major trial

NCT ID NCT06385925

Summary

This study is testing a new drug called TSN1611 for people with advanced solid tumors that have a specific genetic change called KRAS G12D. The first part aims to find the safest and most effective dose, and the second part will see how well the drug works alone or combined with other cancer treatments. It is for adults with cancers like pancreatic, colorectal, or lung cancer who have run out of standard treatment options.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Anhui Provincial Cancer Hospital

    RECRUITING

    Hefei, Anhui, China

    Contact

    Contact

  • Beijing Cancer Hospital

    RECRUITING

    Beijing, Beijing Municipality, China

    Contact

    Contact

  • Beijing Cancer Hospital, Beijing, China

    RECRUITING

    Beijing, 100142, China

    Contact

    Contact

  • Hubei Cancer Hospital

    RECRUITING

    Wuhan, Hubei, China

    Contact

    Contact

  • Hunan Cancer Hospital

    RECRUITING

    Changsha, Hunan, China

    Contact

    Contact

  • Linyi Cancer Hospital

    RECRUITING

    Linyi, Shandong, China

    Contact

    Contact

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact

  • NEXT Oncology

    RECRUITING

    San Antonio, Texas, 78229, United States

    Contact

  • NEXT Virginia

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact

  • Shanghai Chest Hospital, Shanghai, China

    RECRUITING

    Shanghai, 200030, China

    Contact

    Contact

  • Shanghai Tenth People's Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, China

    Contact

    Contact

  • Shanghai Zhongshan Hospital, Shanghai, China

    RECRUITING

    Shanghai, 200032, China

    Contact

    Contact

  • Sir Run Run Shaw Hospital - Zhejiang University School of Med

    RECRUITING

    Hangzhou, Zhejiang, China

    Contact

    Contact

  • Taizhou Hospital of Zhejiang Province

    RECRUITING

    Taizhou, Zhejiang, China

    Contact

    Contact

  • The First Affiliated Hospital - Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, China

    Contact

    Contact

  • The First Affiliated Hospital of Guangzhou Medical University

    RECRUITING

    Guangzhou, Guangdong, China

    Contact

    Contact

  • The First Affiliated Hospital of Nanchang University - Donghu District

    RECRUITING

    Nanchang, Jiang, China

    Contact

    Contact

    Contact

    Contact

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, China

    Contact

    Contact

  • West China Hospital, Sichuan University

    RECRUITING

    Chengdu, Sichuan, China

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.